Administration of the Nod2 synthetic ligand, MDP, attenuates trinitrobenzene sulfonic acid (TNBS) or dextran sodium sulfate (DSS) induced colitis through the down-regulation of several TLR responses [68]. This evidence concerns the gene NOD2 and colitis.